Noemalife

Noemalife S.p.A. was a European provider of clinical and hospital information systems. The company developed and distributed software to manage clinical-healthcare processes at departmental, enterprise, and regional levels. Its flagship product, Galileo, was an eHealth application platform designed to facilitate information exchange among various stakeholders in the patient care process. The platform was utilized in numerous hospitals across Germany, Italy, and Latin America.

Founded in Italy, Noemalife became a significant entity in the healthcare IT sector over a span of more than two decades, recognized for its advanced software and research. In June 2016, the company was acquired by Dedalus S.p.A., a major player in the Italian healthcare software market. The acquisition involved Dedalus purchasing over 83% of Noemalife from key shareholders, including founder Francesco Serra and Tamburi Investment Partners. This merger was aimed at creating the largest healthcare software operator in Italy and one of the largest in Europe, with operations in over 25 countries. Following the acquisition, Noemalife was integrated into Dedalus' broader portfolio of healthcare IT solutions. Official records indicate that the company, as a separate entity, has ceased operations.

Keywords: hospital information systems, clinical information systems, healthcare IT, electronic medical records, EMR, healthcare software, clinical data management, eHealth platform, Galileo software, Dedalus, healthcare process management, diagnostic departments software, patient care technology, medical records systems, healthcare technology integration